Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies
Background. Adenomatous polyposis coli (APC) is widely known as an antagonist of the Wnt signaling pathway via the inactivation of β-catenin. An increasing number of studies have reported that APC methylation contributes to the predisposition to breast cancer (BC). However, recent studies have yield...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2016-07-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/2203.pdf |
_version_ | 1797417661181722624 |
---|---|
author | Dan Zhou Weiwei Tang Wenyi Wang Xiaoyan Pan Han-Xiang An Yun Zhang |
author_facet | Dan Zhou Weiwei Tang Wenyi Wang Xiaoyan Pan Han-Xiang An Yun Zhang |
author_sort | Dan Zhou |
collection | DOAJ |
description | Background. Adenomatous polyposis coli (APC) is widely known as an antagonist of the Wnt signaling pathway via the inactivation of β-catenin. An increasing number of studies have reported that APC methylation contributes to the predisposition to breast cancer (BC). However, recent studies have yielded conflicting results. Methods. Herein, we systematically carried out a meta-analysis to assess the correlation between APC methylation and BC risk. Based on searches of the Cochrane Library, PubMed, Web of Science and Embase databases, the odds ratio (OR) with 95% confidence interval (CI) values were pooled and summarized. Results. A total of 31 articles involving 35 observational studies with 2,483 cases and 1,218 controls met the inclusion criteria. The results demonstrated that the frequency of APC methylation was significantly higher in BC cases than controls under a random effect model (OR = 8.92, 95% CI [5.12–15.52]). Subgroup analysis further confirmed the reliable results, regardless of the sample types detected, methylation detection methods applied and different regions included. Interestingly, our results also showed that the frequency of APC methylation was significantly lower in early-stage BC patients than late-stage ones (OR = 0.62, 95% CI [0.42–0.93]). Conclusion. APC methylation might play an indispensable role in the pathogenesis of BC and could be regarded as a potential biomarker for the diagnosis of BC. |
first_indexed | 2024-03-09T06:21:53Z |
format | Article |
id | doaj.art-6b67fe56dc0f488d9b854caa477fcd60 |
institution | Directory Open Access Journal |
issn | 2167-8359 |
language | English |
last_indexed | 2024-03-09T06:21:53Z |
publishDate | 2016-07-01 |
publisher | PeerJ Inc. |
record_format | Article |
series | PeerJ |
spelling | doaj.art-6b67fe56dc0f488d9b854caa477fcd602023-12-03T11:35:55ZengPeerJ Inc.PeerJ2167-83592016-07-014e220310.7717/peerj.2203Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studiesDan Zhou0Weiwei Tang1Wenyi Wang2Xiaoyan Pan3Han-Xiang An4Yun Zhang5Department of Translational Medicine, Xiamen Institute of Rare Earth Materials, Xiamen, ChinaDepartment of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, ChinaDepartment of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, ChinaDepartment of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, ChinaDepartment of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, ChinaDepartment of Translational Medicine, Xiamen Institute of Rare Earth Materials, Xiamen, ChinaBackground. Adenomatous polyposis coli (APC) is widely known as an antagonist of the Wnt signaling pathway via the inactivation of β-catenin. An increasing number of studies have reported that APC methylation contributes to the predisposition to breast cancer (BC). However, recent studies have yielded conflicting results. Methods. Herein, we systematically carried out a meta-analysis to assess the correlation between APC methylation and BC risk. Based on searches of the Cochrane Library, PubMed, Web of Science and Embase databases, the odds ratio (OR) with 95% confidence interval (CI) values were pooled and summarized. Results. A total of 31 articles involving 35 observational studies with 2,483 cases and 1,218 controls met the inclusion criteria. The results demonstrated that the frequency of APC methylation was significantly higher in BC cases than controls under a random effect model (OR = 8.92, 95% CI [5.12–15.52]). Subgroup analysis further confirmed the reliable results, regardless of the sample types detected, methylation detection methods applied and different regions included. Interestingly, our results also showed that the frequency of APC methylation was significantly lower in early-stage BC patients than late-stage ones (OR = 0.62, 95% CI [0.42–0.93]). Conclusion. APC methylation might play an indispensable role in the pathogenesis of BC and could be regarded as a potential biomarker for the diagnosis of BC.https://peerj.com/articles/2203.pdfBreast cancerAPCMethylationMeta-analysis |
spellingShingle | Dan Zhou Weiwei Tang Wenyi Wang Xiaoyan Pan Han-Xiang An Yun Zhang Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies PeerJ Breast cancer APC Methylation Meta-analysis |
title | Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies |
title_full | Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies |
title_fullStr | Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies |
title_full_unstemmed | Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies |
title_short | Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies |
title_sort | association between aberrant apc promoter methylation and breast cancer pathogenesis a meta analysis of 35 observational studies |
topic | Breast cancer APC Methylation Meta-analysis |
url | https://peerj.com/articles/2203.pdf |
work_keys_str_mv | AT danzhou associationbetweenaberrantapcpromotermethylationandbreastcancerpathogenesisametaanalysisof35observationalstudies AT weiweitang associationbetweenaberrantapcpromotermethylationandbreastcancerpathogenesisametaanalysisof35observationalstudies AT wenyiwang associationbetweenaberrantapcpromotermethylationandbreastcancerpathogenesisametaanalysisof35observationalstudies AT xiaoyanpan associationbetweenaberrantapcpromotermethylationandbreastcancerpathogenesisametaanalysisof35observationalstudies AT hanxiangan associationbetweenaberrantapcpromotermethylationandbreastcancerpathogenesisametaanalysisof35observationalstudies AT yunzhang associationbetweenaberrantapcpromotermethylationandbreastcancerpathogenesisametaanalysisof35observationalstudies |